Literature DB >> 8520401

Parvovirus B19: an expanding spectrum of disease.

B Cohen1.   

Abstract

Entities:  

Mesh：

Year:  1995        PMID： 8520401      PMCID： PMC2548210          DOI： 10.1136/bmj.311.7019.1549

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  39 in total

1.  Hypoplastic anemia in a hemophiliac first infused with a solvent/detergent treated factor VIII concentrate: the role of human B19 parvovirus.

Authors:  M Morfini; G Longo; P Rossi Ferrini; A Azzi; C Zakrewska; S Ciappi; P Kolumban
Journal:  Am J Hematol       Date:  1992-02       Impact factor: 10.047

2.  Persistent B19 parvovirus infection as a cause of severe chronic anaemia in children with acute lymphocytic leukaemia.

Authors:  G J Kurtzman; B Cohen; P Meyers; A Amunullah; N S Young
Journal:  Lancet       Date:  1988-11-19       Impact factor: 79.321

3.  Numbness and tingling of fingers associated with parvovirus B19 infection.

Authors:  H Faden; G W Gary; M Korman
Journal:  J Infect Dis       Date:  1990-02       Impact factor: 5.226

4.  Prolonged parvovirus B19 infection with severe anaemia in a bone marrow transplant patient.

Authors:  H T Weiland; M M Salimans; W E Fibbe; P M Kluin; B J Cohen
Journal:  Br J Haematol       Date:  1989-02       Impact factor: 6.998

5.  Symptomatic parvovirus B19 infection and heat-treated factor IX concentrate.

Authors:  D J Lyon; C S Chapman; C Martin; K E Brown; J P Clewley; A J Flower; V E Mitchell
Journal:  Lancet       Date:  1989-05-13       Impact factor: 79.321

6.  Neuralgic amyotrophy due to parvovirus infection.

Authors:  D W Denning; A Amos; P Rudge; B J Cohen
Journal:  J Neurol Neurosurg Psychiatry       Date:  1987-05       Impact factor: 10.154

7.  Chronic bone marrow failure due to persistent B19 parvovirus infection.

Authors:  G J Kurtzman; K Ozawa; B Cohen; G Hanson; R Oseas; N S Young
Journal:  N Engl J Med       Date:  1987-07-30       Impact factor: 91.245

8.  B19 parvovirus infection of myocardial cells.

Authors:  H J Porter; A M Quantrill; K A Fleming
Journal:  Lancet       Date:  1988-03-05       Impact factor: 79.321

9.  Persistent B19 parvovirus infection in patients infected with human immunodeficiency virus type 1 (HIV-1): a treatable cause of anemia in AIDS.

Authors:  N Frickhofen; J L Abkowitz; M Safford; J M Berry; J Antunez-de-Mayolo; A Astrow; R Cohen; I Halperin; L King; D Mintzer
Journal:  Ann Intern Med       Date:  1990-12-15       Impact factor: 25.391

10.  Persistence of B19 parvovirus in synovial membranes of patients with rheumatoid arthritis.

Authors:  J G Saal; M Steidle; H Einsele; C A Müller; P Fritz; J Zacher
Journal:  Rheumatol Int       Date:  1992       Impact factor: 2.631
View more
  11 in total

1.  Managing viral exposure during pregnancy.

Authors:  J D Goldberg
Journal:  West J Med       Date:  1996-12

2.  Parvovirus B19 during pregnancy: a review.

Authors:  Elsa Giorgio; Maria Antonietta De Oronzo; Irene Iozza; Angela Di Natale; Stefano Cianci; Giovanna Garofalo; Anna Maria Giacobbe; Salvatore Politi
Journal:  J Prenat Med       Date:  2010-10

3.  Epidemiological and clinical characteristics of human parvovirus B19 infections during 2006-2009 in Northern Greece.

Authors:  M Exindari; D Chatzidimitriou; A Melidou; G Gioula; L Ziogou; E Diza
Journal:  Hippokratia       Date:  2011-04       Impact factor: 0.471

4.  Quantification of parvovirus B19 DNA using COBAS AmpliPrep automated sample preparation and LightCycler real-time PCR.

Authors:  Stefan Schorling; Gunnar Schalasta; Gisela Enders; Michael Zauke
Journal:  J Mol Diagn       Date:  2004-02       Impact factor: 5.568

5.  Model structure analysis to estimate basic immunological processes and maternal risk for parvovirus B19.

Authors:  Nele Goeyvaerts; Niel Hens; Marc Aerts; Philippe Beutels
Journal:  Biostatistics       Date:  2010-09-14       Impact factor: 5.899

6.  Pattern of parvovirus B 19 infection during different trimesters of pregnancy in Kuwait.

Authors:  M Makhseed; A Pacsa; M A Ahmed; S S Essa
Journal:  Infect Dis Obstet Gynecol       Date:  1999

7.  Parvovirus B19 diagnosis in pregnant women--quantification of IgG antibody levels (IU/ml) with reference to the international parvovirus B19 standard serum.

Authors:  K Searle; C Guilliard; G Enders
Journal:  Infection       Date:  1997 Jan-Feb       Impact factor: 7.455

8.  The prevalence of parvovirus B19 infection among pregnant women of Ardabil in 2013.

Authors:  Shahram Habibzadeh; Hadi Peeri-Doghaheh; Jafar Mohammad-Shahi; Elham Mobini; Samira Shahbazzadegan
Journal:  Iran J Microbiol       Date:  2016-06

9.  Acute arthropathy in patients with rash diseases: a comparative study.

Authors:  Solange Artimos de Oliveira; Luiz Antonio Bastos Camacho; Letícia Fernandes Bruno; Rodrigo Coimbra de Gusmão; Antonio Carlos de Medeiros Pereira; Luis Guillermo Coca Velarde; Marilda Mendonça Siqueira
Journal:  Clin Rheumatol       Date:  2009-05-05       Impact factor: 3.650

10.  Acute parvovirus B19 infection in pregnant women--an analysis of serial samples by serological and semi-quantitative PCR techniques.

Authors:  K Searle; C Guilliard; S Wallat; G Schalasta; G Enders
Journal:  Infection       Date:  1998 May-Jun       Impact factor: 7.455
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.